Molecular Signaling in Metabolic Disease
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: closed (26 June 2023) | Viewed by 424
Special Issue Editors
Interests: diabetes; biomarkers; metabolic disease; obesity; inflammation; non-alcoholic fatty liver disease; lipids; CVD; molecular mechanism; pharmacotherapeutics
Special Issue Information
Dear Colleagues,
Metabolic disease, a collection of disorders that are related to pathophysiological defects in using and/or converting energy, has been emerging as a major condition affecting a huge percentage of the population, leading to a rise in related health problems with a higher incidence of all-cause mortality worldwide.
Now more than ever, attention should be dedicated to advancing our knowledge of the molecular mechanisms involved in the development and progression of metabolic disease. Further studies are required to identify new potential mechanisms implicated in the development of these alterations and/or potential targets (i.e., new biomarkers, signaling molecules, epigenetic reprogramming, exosomes, gut microbiome, etc.) that could help to develop new strategies and therapeutic modalities aimed at preventing and/or reversing the complications associated with metabolic diseases.
This Special Issue, “Molecular Signaling in Metabolic Disease”, aims to highlight the up-to-date progress that has shaped the field in recent years. We strive to establish a collection of high-quality articles covering all aspects of human metabolic diseases, such as obesity, type 1 and 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and cancer. Work with strong translational potential is encouraged to shed light on the development of new therapeutic approaches to improve the clinical management of these metabolic disorders.
We invite prospective authors to contribute to the Special Issue hypothesis-driven research generated with the highest standards that paves the way to novel molecular signaling understanding in any aspect of translational and clinical metabolic research. Submissions related to both existing and future therapies or treatment alternatives for metabolic disease, as well as validation of the existing research in addition to investigations into mechanistic exploration that lead to metabolic disorders, are also welcome.
Dr. Shengshuai Shan
Dr. Qiuhua Yang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- obesity
- metabolic syndrome (MetS)
- biomarkers
- insulin resistance
- dyslipidemia
- nonalcoholic fatty liver disease (NAFLD)
- cardiovascular diseases (CVD)
- cancer
- molecular mechanism
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
